mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NC_000913_3_bme_pgi | 526,796 | 0 | C | G | 41.0% | 22.3 / 44.0 | 39 | A1179G (GCG→GGG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 526,792 | 0 | A | C | 40.5% | 25.0 / 30.8 | 38 | S1178R (AGC→CGC) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 526,800 | 0 | A | G | 40.5% | 18.7 / 35.1 | 37 | E1180E (GAA→GAG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 4,296,061 | 0 | C | T | 30.0% | 45.8 / 27.4 | 42 | intergenic (+266/+376) | gltP/yjcO | glutamate/aspartate:proton symporter/Sel1 family TPR‑like repeat protein |
| * | NC_000913_3_bme_pgi | 3,156,590 | 0 | C | A | 21.1% | 71.2 / 18.1 | 38 | intergenic (+72/‑33) | yqhD/dkgA | aldehyde reductase, NADPH‑dependent/2,5‑diketo‑D‑gluconate reductase A |
| * | NC_000913_3_bme_pgi | 3,156,591 | 0 | T | G | 21.1% | 57.6 / 19.1 | 38 | intergenic (+73/‑32) | yqhD/dkgA | aldehyde reductase, NADPH‑dependent/2,5‑diketo‑D‑gluconate reductase A |
| Marginal new junction evidence (lowest skew 10 of 109 shown) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NC_000913_3_bme_pgi | = 373065 | 32 (1.060) | 4 (0.150) | 4/252 | 3.5 | 12.1% | coding (145/951 nt) | mhpF | acetaldehyde‑CoA dehydrogenase II, NAD‑binding |
| ? | NC_000913_3_bme_pgi | = 373047 | 30 (1.130) | coding (127/951 nt) | mhpF | acetaldehyde‑CoA dehydrogenase II, NAD‑binding | |||||
| * | ? | NC_000913_3_bme_pgi | 1987843 = | 16 (0.530) | 4 (0.140) | 4/272 | 3.8 | 19.0% | intergenic (‑85/+30) | yecJ/azuC | DUF2766 family protein/acid‑inducible small membrane‑associated protein |
| ? | NC_000913_3_bme_pgi | 1987874 = | 19 (0.660) | coding (86/87 nt) | azuC | acid‑inducible small membrane‑associated protein | |||||
| * | ? | NC_000913_3_bme_pgi | 1381325 = | 24 (0.790) | 4 (0.140) | 4/274 | 3.8 | 15.1% | pseudogene (505/957 nt) | ycjV | pseudogene; putative ATP‑binding component of a transport system |
| ? | NC_000913_3_bme_pgi | 1381347 = | 22 (0.760) | pseudogene (527/957 nt) | ycjV | pseudogene; putative ATP‑binding component of a transport system | |||||
| * | ? | NC_000913_3_bme_pgi | 699425 = | NA (NA) | 4 (0.140) | 4/274 | 3.8 | NA | noncoding (1/98 nt) | RIP61 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site | RIP61 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site |
| ? | NC_000913_3_bme_pgi | 2842453 = | NA (NA) | noncoding (31/79 nt) | REP197 (repetitive extragenic palindromic) element; contains 2 REP sequences | REP197 (repetitive extragenic palindromic) element; contains 2 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | = 375294 | 56 (1.850) | 4 (0.140) | 4/274 | 3.8 | 6.9% | noncoding (365/436 nt) | REP31 (repetitive extragenic palindromic) element; contains 9 REP sequences | REP31 (repetitive extragenic palindromic) element; contains 9 REP sequences |
| ? | NC_000913_3_bme_pgi | = 375312 | 55 (1.910) | noncoding (383/436 nt) | REP31 (repetitive extragenic palindromic) element; contains 9 REP sequences | REP31 (repetitive extragenic palindromic) element; contains 9 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | = 375218 | 37 (1.220) | 4 (0.140) | 4/274 | 3.8 | 8.4% | noncoding (289/436 nt) | REP31 (repetitive extragenic palindromic) element; contains 9 REP sequences | REP31 (repetitive extragenic palindromic) element; contains 9 REP sequences |
| ? | NC_000913_3_bme_pgi | = 375287 | 52 (1.800) | noncoding (358/436 nt) | REP31 (repetitive extragenic palindromic) element; contains 9 REP sequences | REP31 (repetitive extragenic palindromic) element; contains 9 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | = 375117 | 35 (1.150) | 4 (0.140) | 4/274 | 3.8 | 8.6% | noncoding (188/436 nt) | REP31 (repetitive extragenic palindromic) element; contains 9 REP sequences | REP31 (repetitive extragenic palindromic) element; contains 9 REP sequences |
| ? | NC_000913_3_bme_pgi | = 375287 | 52 (1.800) | noncoding (358/436 nt) | REP31 (repetitive extragenic palindromic) element; contains 9 REP sequences | REP31 (repetitive extragenic palindromic) element; contains 9 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | = 4076597 | 30 (0.990) | 4 (0.140) | 4/280 | 3.9 | 12.3% | coding (452/873 nt) | yihY | BrkB family putative transporter, inner membrane protein |
| ? | NC_000913_3_bme_pgi | = 4076609 | 28 (0.950) | coding (464/873 nt) | yihY | BrkB family putative transporter, inner membrane protein | |||||
| * | ? | NC_000913_3_bme_pgi | 3895222 = | 29 (0.960) | 3 (0.110) | 3/264 | 4.2 | 10.6% | intergenic (+4/+50) | chrR/adeP | chromate reductase, Class I, flavoprotein/adenine permease, high affinity; adenine:H+ symporter |
| ? | NC_000913_3_bme_pgi | 3895257 = | 24 (0.860) | intergenic (+39/+15) | chrR/adeP | chromate reductase, Class I, flavoprotein/adenine permease, high affinity; adenine:H+ symporter | |||||
| * | ? | NC_000913_3_bme_pgi | 2635831 = | 32 (1.060) | 3 (0.110) | 3/262 | 4.2 | 9.2% | intergenic (‑17/+53) | yfgJ/der | DUF1407 family protein/GTPase; multicopy suppressor of ftsJ |
| ? | NC_000913_3_bme_pgi | 2635863 = | 30 (1.090) | intergenic (‑49/+21) | yfgJ/der | DUF1407 family protein/GTPase; multicopy suppressor of ftsJ | |||||